Blog
Insights on peptide prescribing, compounding, and regulatory developments.
Informed Consent for Compounded Peptides: What You Need to Document
Informed consent for compounded medications carries unique requirements. Learn what to include, common mistakes that create liability, and how to keep consent forms current as regulations change.
BPC-157 Prescribing Guide: Dosing, Protocols, and Clinical Considerations
Everything physicians need to know about prescribing BPC-157. Mechanism of action, FDA regulatory status, dosing protocols, lab monitoring, contraindications, and informed consent considerations.
503A vs 503B Compounding Pharmacies: What Prescribers Need to Know
A clear breakdown of the differences between 503A and 503B compounding pharmacies, when to use each, and how to vet a pharmacy partner for peptide prescribing.
How to Start Prescribing Peptides: A Physician's Complete Guide
A practical guide for physicians entering peptide therapy. Covers which peptides are legally available, how to choose a compounding pharmacy, basic protocol structure, and compliance essentials.
The Cash-Pay Prescribing Stack: Software for Clinics Beyond Insurance
Insurance-based e-prescribing doesn't work for cash-pay clinics. Here's what the emerging software stack looks like for clinics prescribing compounded medications, peptides, and specialty compounds.
FDA Peptide Reclassification 2026: What the Category 2 to Category 1 Shift Means for Providers and Pharmacies
The FDA is moving key peptides from Category 2 back to Category 1, reopening the compounding market. Here's what providers and compound pharmacies need to know about timelines, compliance, and operational readiness.